Launch marks Zentiva's strategic entry into biosimilars and reinforces its mission to broaden patient access to high-quality biologic medicines across Europe. PRAGUE, Dec. 1, 2025 /PRNewswire/ -- ...
Creditors are ready to provide debt financing in the amount of 3 billion euros as part of the proposed acquisition of the manufacturer of Zentiva generics. This is reported by foreign media. Earlier, ...
The American investment company GTCR LLC is negotiating with creditors to raise financing as part of the proposed acquisition of Zentiva, a generic drug manufacturer controlled by Advent International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback